CFO transition
The Lovesac Company CFO transition: Andrew Farag to succeed Keith Siegner
The Lovesac Company reported in a Form 8-K filed June 15, 2026 that Andrew Farag will succeed Keith Siegner as Executive Vice President, Chief Financial Officer and Treasurer, effective June 15, 2026.
In the filing's words
On June 10, 2026, the Board of Directors (the “Board”) of The Lovesac Company (the “Company”) appointed Mr. Andrew Farag to serve as principal accounting officer, Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective June 15, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | The Lovesac Company (LOVE) |
|---|---|
| Event | Transition |
| Incoming | Andrew Farag |
| Outgoing | Keith Siegner |
| Title in the filing | Executive Vice President, Chief Financial Officer and Treasurer |
| Effective | June 15, 2026 |
| 8-K filed | June 15, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Managing Director, Riveron |
| SEC CIK | 0001701758 |
The Lovesac Company reported this change in a Form 8-K, Item 5.02, filed June 15, 2026. The filing's own words are quoted above.
Other records naming Keith Siegner
1The outgoing officer on this record, matched by name. Career line.
2026-04-02 · 10-K signature
Keith Siegner signed Lovesac Co's annual report as Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
Also filed in June 2026
Other CFO moves on the record that month. All moves.
4 months ago· 2026-06-30TransitionBANX
ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
4 months ago· 2026-06-29TransitionGCO
Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn
4 months ago· 2026-06-29TransitionTNYA
Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Andrew Farag? Send a correction with the primary source.